Product Details
Product Introduction:
High purity yeast RNA(W), in the original yeast RNA sodium based on the color and solubility were improved.
Product features:
Yeast RNA(W) in yeast RNA sodium on the basis of the improvement, remove the colored components and improve the solubility, so that it can be a higher concentration of deployment in gelatin foods and beverages;
The use of FDA food applications approved round yeast for production, safety is guaranteed;
Provide full quality documentation (SPEC, COA) support.
Division I can also demand to provide salmon sperm DNA, DNA-K, DNA-Na, yeast RNA, salmon ovary peptide (SOP) and other raw materials, welcome to consult!
Company Profile
Ganyun Pharmaceutical is a professional supplier focusing on the three major industries of medicine, beauty and food. With system solutions and technical services as the core, it acts as an agent to import injection accessories, nucleic acid raw materials, medicinal glass beads/ceramic beads, biodegradable glitter powder and high-end skin care products. It serves the upstream and downstream of the industrial chain with strict quality standards and provides reliable technical support and supply guarantee for partners.
Basic Information
country
China Mainland
Total Assets
Year of Establishment
2017
Total Number of Employees
Competitive Advantage
Large Product Line,Small Orders Accepted,Reputation,Quality Service
Target Market
This platform provides information display and business services for the food industry only.
All product/service information displayed on this page, including images, specifications, prices,
certifications, and details, is published by merchants who are solely responsible for its
authenticity,
accuracy, and legality. The platform only provides information and transaction matching services and
does not guarantee product quality,
safety, suitability, or transaction performance. Please verify relevant information with suppliers
before purchasing.
If you find any illegal, infringing, or false information, please contact the platform promptly.